Guidelines for the treatment of benign prostatic hyperplasia

Research output: Contribution to specialist publicationArticle

5 Scopus citations

Abstract

Benign prostatic hyperplasia (BPH) is a common disorder in men with an incidence that increases with age. BPH often requires therapy when patients begin to experience lower urinary tract symptoms that affect quality of life. Current management strategies involve lifestyle modifications, pharmacotherapy, phytotherapy, and surgical interventions as indicated. Pharmacists are in the unique position of being accessible sources of healthcare information for the BPH patient population. Understanding the symptoms of this disorder and therapy options will be beneficial for pharmacists who have increased chances to answer BPH-related questions from their patients.

Original languageEnglish (US)
Pages36-40
Number of pages5
Volume41
No8
Specialist publicationU.S. Pharmacist
StatePublished - Aug 1 2016

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Guidelines for the treatment of benign prostatic hyperplasia'. Together they form a unique fingerprint.

Cite this